鹽酸吉西他濱

ChemLeader 98+%

Gemcitabine Hydrochloride | Gemcitabine HCl | LY 188011 hydrochloride | NSC 613327 HCl

產品編號：CL1996A CAS No.：122111-03-9 MDLNo： 分子式：C?H??ClF?N?O? 分子量：299.66

加入收藏分享給朋友

規格	庫存	目錄價	會員專享價	數量
250 mg	In-stock	￥100.00	登錄后可見	- +
500 mg	In-stock	￥150.00	登錄后可見	- +
1 g	In-stock	￥250.00	登錄后可見	- +
5 g	In-stock	￥400.00	登錄后可見	- +

化學品安全說明書(MSDS)

下載MSDS

質檢證書(COA)

下載COA

發送詢價加入購物車

基本信息
相關文檔
產品詳情
相關文獻

基本信息

英文名稱	Gemcitabine Hydrochloride \| Gemcitabine HCl \| LY 188011 hydrochloride \| NSC 613327 HCl
中文名稱	鹽酸吉西他濱
CAS號	122111-03-9
分子式	C?H??ClF?N?O?
分子量	299.66
外觀	White to off-white powder
儲存條件	4°C, sealed storage, away from moisture and light

安全信息

產品詳情

Gemcitabine is an active metabolite of the gemcitabine prodrugs NUC-1031 and gemcitabine elaidate and a prodrug form of gemcitabine di- and triphosphates. Gemcitabine is phosphorylated by intracellular kinases to the intermediate metabolite gemcitabine monophosphate and the active di- and triphosphate forms.It is cytotoxic to HepG2 hepatocellular carcinoma and A549 non-small cell lung cancer (NSCLC) cells (IC50s = 5.2 and 16 nM, respectively) and inhibits tumor growth in various breast, colon, lung, and pancreatic cancer mouse xenograft models. Gemcitabine (12 mg/kg) sensitizes tumors to antibodies targeting programmed cell death protein 1 (PD-1), decreases the number of tumor-infiltrating regulatory T cells (Tregs), and increases survival in an MC-38 syngeneic mouse model of colon carcinoma. Formulations containing gemcitabine have been used in the treatment of cancer.

相關文獻

抱歉，暫時沒有相關文獻

相關產品

抱歉，暫時沒有相關產品

瀏覽記錄

CL1996A

鹽酸吉西他濱

122111-03-9 98+% In-stock

￥100.00 250 mg